Significant Accounting Polices - Additional Information (Details)							3 Months Ended	12 Months Ended
	Jan. 30, 2023 USD ($)	Jan. 14, 2022 USD ($)	Oct. 12, 2021 USD ($)	Mar. 19, 2021 USD ($)	Jan. 25, 2021 USD ($)	Apr. 11, 2020 USD ($)	Jun. 30, 2021 USD ($)	Dec. 31, 2022 USD ($) Segment	Dec. 31, 2021 USD ($)	Mar. 31, 2023 USD ($)	Mar. 04, 2022 USD ($)	Oct. 04, 2021 USD ($)
Schedule Of Significant Accounting Policies [Line Items]
Upfront nonrefundable payment					$ 1,000,000.0
Reimbursement payment				$ 14,000,000.0
Collaboration Agreement Amount				25,000,000.0
Development payments				10,000,000.0
Deferred collaboration funding								$ 8,400,000
Deferred collaboration funding, current								8,412,971	$ 15,825,938
Cash in excess of FDIC insured limit								2,100,000	12,500,000
Cash and cash equivalents								$ 2,329,218	12,710,762
Expected term of stock option granted to employees and directors, average contractual term and vesting period								10 years
Uncertain tax positions, accruals								$ 0	0
Accruals for interest or penalties related to income tax matters								$ 0	0
Number of operating segment | Segment								1
ASU No. 2020-06
Schedule Of Significant Accounting Policies [Line Items]
Change in Accounting Principle, Accounting Standards Update, Adopted [true false]								true
Change in Accounting Principle, Accounting Standards Update, Adoption Date								Mar. 31, 2021
ASU No. 2021-04
Schedule Of Significant Accounting Policies [Line Items]
Change in Accounting Principle, Accounting Standards Update, Adopted [true false]								true
Change in Accounting Principle, Accounting Standards Update, Adoption Date								Mar. 31, 2022
Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]								true
ASU No. 2021-10
Schedule Of Significant Accounting Policies [Line Items]
Change in Accounting Principle, Accounting Standards Update, Adopted [true false]								true
Change in Accounting Principle, Accounting Standards Update, Adoption Date								Dec. 31, 2021
Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]								true
PPP Loan | JPMorgan Chase Bank, N.A
Schedule Of Significant Accounting Policies [Line Items]
CARES act of 2020 aid loan amount						$ 600,000
Accounts Payable and Accrued Expenses
Schedule Of Significant Accounting Policies [Line Items]
Preclinical or clinical study expense								$ 900,000	200,000
Maximum
Schedule Of Significant Accounting Policies [Line Items]
Cash, FDIC insured amount								250,000
Relief
Schedule Of Significant Accounting Policies [Line Items]
Non-cash reduction recognized in secured loan									4,000,000.0
Collaboration Agreement | Second Development Payment
Schedule Of Significant Accounting Policies [Line Items]
Deferred collaboration funding								8,400,000
Deferred collaboration funding, current								8,400,000
Deferred collaboration funding, cash received								$ 35,000,000.0
Revenue recognized									1,300,000
Offset to research and development expenses									13,900,000
Offset to general and administrative expenses									$ 11,400,000
Collaboration Agreement | Relief
Schedule Of Significant Accounting Policies [Line Items]
Cash payment received				10,000,000.0	10,000,000.0		$ 10,000,000.0
Reimbursement payment				14,000,000.0	14,000,000.0
Repayment of outstanding balance of prior loan and interest				$ 4,000,000.0	$ 4,000,000.0
Net profit split ratio based on territory				60.00%	60.00%
Percentage of royalty net sales received				15.00%	15.00%
Milestone payment to be received				$ 6,000,000.0	$ 6,000,000.0
Potential proceeds from development payments subject to new drug application												$ 10,000,000.0
Proceeds from first tranche of development payments subject to new drug application			$ 5,000,000.0
Percentage of development and commercialization services				60.00%
Percentage of payment net profit territory				60.00%
Upfront non-refundable payment received					$ 1,000,000.0
Development payments				$ 20,000,000.0
Collaboration Agreement | Relief | Secured Loan
Schedule Of Significant Accounting Policies [Line Items]
Debt instrument, term					12 months
Debt instrument principal amount					$ 4,000,000.0
Debt instrument, interest rate					6.00%
Collaboration Agreement | Relief | Maximum
Schedule Of Significant Accounting Policies [Line Items]
Development and commercial launch costs					$ 20,000,000.0
Development payments				20,000,000.0
Collaboration Agreement | Relief | Second Development Payment
Schedule Of Significant Accounting Policies [Line Items]
Proceeds from first tranche of development payments subject to new drug application			5,000,000.0
Waiver and Agreement | Relief | Second Development Payment
Schedule Of Significant Accounting Policies [Line Items]
Proceeds from first tranche of development payments subject to new drug application		$ 5,000,000.0	$ 5,000,000.0
Proposed Collaboration and License Agreement
Schedule Of Significant Accounting Policies [Line Items]
Upfront non-refundable payment received				$ 1,000,000.0
Proposed Collaboration and License Agreement | Relief
Schedule Of Significant Accounting Policies [Line Items]
Upfront non-refundable payment received					$ 1,000,000.0
Proposed Collaboration and License Agreement | Relief | Secured Loan
Schedule Of Significant Accounting Policies [Line Items]
Debt instrument, term					12 months
Debt instrument principal amount					$ 4,000,000.0
Debt instrument, interest rate					6.00%
SWK Credit Agreement | Lenders Party and SWK | Original Term Loan
Schedule Of Significant Accounting Policies [Line Items]
Debt instrument principal amount											$ 6,500,000
Debt instrument, interest rate								15.80%
SWK Credit Agreement | Lenders Party and SWK | Original Term Loan | Scenario Forecast
Schedule Of Significant Accounting Policies [Line Items]
Minimum cash balance required by the loan covenants										$ 3,000,000.0
SWK Credit Agreement | Lenders Party and SWK | Original Term Loan | Subsequent Event
Schedule Of Significant Accounting Policies [Line Items]
Minimum cash balance required by the loan covenants	$ 1,500,000
Number of days required for cash balance	14 days